WO2014158747A1 - Large bore closure secondary hemostasis bioadhesive delivery systems and methods - Google Patents

Large bore closure secondary hemostasis bioadhesive delivery systems and methods Download PDF

Info

Publication number
WO2014158747A1
WO2014158747A1 PCT/US2014/019808 US2014019808W WO2014158747A1 WO 2014158747 A1 WO2014158747 A1 WO 2014158747A1 US 2014019808 W US2014019808 W US 2014019808W WO 2014158747 A1 WO2014158747 A1 WO 2014158747A1
Authority
WO
WIPO (PCT)
Prior art keywords
suture
puncture
sealant
delivery device
sealant delivery
Prior art date
Application number
PCT/US2014/019808
Other languages
French (fr)
Inventor
Martha ESCOBAR
Scott Kramer
Edward E. Parsonage
Scott Smith
Original Assignee
St. Jude Medical Puerto Rico Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St. Jude Medical Puerto Rico Llc filed Critical St. Jude Medical Puerto Rico Llc
Priority to EP14772819.0A priority Critical patent/EP2967565B1/en
Publication of WO2014158747A1 publication Critical patent/WO2014158747A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0482Needle or suture guides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • A61B2017/00495Surgical glue applicators for two-component glue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/0065Type of implements the implement being an adhesive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/00654Type of implements entirely comprised between the two sides of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00646Type of implements
    • A61B2017/00663Type of implements the implement being a suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0472Multiple-needled, e.g. double-needled, instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06004Means for attaching suture to needle
    • A61B2017/06042Means for attaching suture to needle located close to needle tip

Definitions

  • the present disclosure relates generally to methods and systems for sealing tissue punctures, and more particularly, to methods and systems for sealing large bore openings in vessels using multiple closure mechanisms.
  • vascular disease such as arteriosclerosis
  • an instrument e.g., a balloon or other type of catheter
  • Such procedures usually involve the percutaneous puncture of the artery so that an insertion sheath may be placed in the artery and thereafter instruments (e.g., catheters) may pass through the sheath to an operative position within the artery.
  • instruments e.g., catheters
  • Intravascular and intraluminal procedures unavoidably present the problem of stopping the bleeding at the percutaneous puncture after the procedure has been completed and after the instruments (and any insertion sheaths used therewith) have been removed. Bleeding from puncture sites, particularly in the case of femoral arterial punctures, is typically stopped by utilizing vascular closure devices.
  • one method includes temporarily sealing the tissue puncture intravascularly using an inflation balloon.
  • a sealing material may be delivered to an outer surface of the tissue to seal the tissue puncture.
  • Closing large bore openings in a vessel may be particularly difficult using a pre-formed or flowable sealing material on an exterior surface of the vessel.
  • the vascular closure assembly includes a suture placement device and a sealant delivery device.
  • the suture placement device is operable to position at least one suture across the puncture to form a primary seal of the puncture.
  • the sealant delivery device includes a sealant delivery tube having a first lumen sized to receive the at least one suture, and a second lumen configured to deliver a volume of sealant to the puncture after forming the primary seal to create a secondary seal of the puncture.
  • the sealant delivery device is slidable along the at least one suture to the puncture.
  • the sealant delivery tube may include a suture insertion slot at a distal end of the sealant delivery tube.
  • the sealant delivery tube may include a helical shaped suture insertion slot at a distal end thereof, and a longitudinal guide slot open to the helical shaped suture insertion slot.
  • the sealant delivery tube may include a helical shaped suture insertion slot at a distal end thereof, wherein the insertion slot forms an acute angle along its length.
  • the sealant delivery device may include a suture retaining member positioned at a distal end thereof, wherein the suture retaining member permits one-way insertion of the at least one suture into the first lumen.
  • the suture placement device may position the at least one suture on opposite sides of the puncture, and tension may be retained in the at least one suture with one of a knot and a suture locking device to at least partially seal the puncture prior to delivering the volume of sealant.
  • Another aspect of the present disclosure relates to a method of closing a puncture in a vessel.
  • the method includes providing a suture placement device and a sealant delivery device, positioning at least one suture across the puncture with the suture placement device, sealing the puncture with the at least one suture, advancing the sealant delivery device along the at least one suture to the puncture, and delivering a volume of sealant through the sealant delivery device to the puncture to further seal the puncture.
  • the method may also include providing a releasable connection between the sealant delivery device and the at least one suture.
  • Delivering a volume of sealant may include mixing the volume of sealant in the sealant delivery device during delivery.
  • the sealant delivery device may include a first lumen configured to receive the at least one suture and a second lumen configured to deliver the volume of sealant.
  • Sealing the puncture may include advancing a knot along the at least one suture to the puncture.
  • the at least one suture may include two suture portions and the sealant delivery device may be advanced along both suture portions to the puncture.
  • the sealant delivery device may include a sealant shaft and an insertion slot extending proximally from an open distal end of the sealant shaft, and the method may include inserting the at least one suture into the insertion slot prior to advancing the sealant delivery device.
  • the sealant delivery device may include a guide slot spaced proximal of the open distal end and intersecting with the insertion slot, and the method may include inserting the at least one suture through the insertion slot and into the guide slot prior to advancing the sealant delivery device.
  • the method may include inserting the at least one suture into a portion of the sealant delivery device before advancing the sealant delivery device.
  • Another example method in accordance with the present disclosure relates to sealing a puncture in a vessel accessible through a percutaneous incision.
  • the method includes providing a sealant delivery device having first and second lumens, and a suture placement device, positioning at least one suture across the puncture with the suture placement device, advancing a knot along the at least one suture to seal the puncture, positioning the at least one suture in the first lumen, advancing the sealant delivery device along the at least one suture to the puncture, and delivering a volume of sealant through the second lumen to the puncture to seal the puncture.
  • the sealant delivery device may include a helical shaped insertion slot providing lateral access into the first lumen, and positioning the at least one suture in the first lumen includes laterally inserting the at least one suture through the insertion slot.
  • the sealant delivery device may include a guide slot intersecting the insertion slot and extending longitudinally, and positioning the at least one suture in the first lumen includes positioning the at least one suture in the guide slot.
  • the sealant may include a resorbable bioadhesive.
  • Positioning at least one suture across the puncture with the suture placement device may include inserting the suture placement device in the puncture, advancing at least one needle through a wall of the vessel adjacent to the puncture, drawing the at least one suture through the wall of the vessel, and removing the suture placement device from the puncture.
  • FIG. 1 shows components of an example vascular closure system in accordance with the present disclosure.
  • FIG. 1A is a cross-sectional view of a sealant delivery device of the vascular closure system shown in FIG. 1 taken along cross-sectional indicators 1A-1A.
  • FIG. IB is a close-up view of a distal end portion of the sealant delivery device of the vascular closure system of FIG. 1.
  • FIG. 2A is a close-up view of a distal end portion of another example sealant delivery device.
  • FIG. 2B is an end view of the sealant delivery device of FIG. 2A.
  • FIG. 3A is a close-up view of a distal end portion of another example sealant delivery device.
  • FIG. 3B is an end view of the sealant delivery device of FIG. 3A in a closed position.
  • FIG. 3 C is an end view of the sealant delivery device of FIG. 3 A in an open position.
  • FIGS. 4-10 show steps of an example method of sealing a vessel puncture using the vascular closure system of FIG. 1.
  • the systems disclosed herein may be used to close or seal percutaneous punctures made through the body tissue of a patient to gain access to a body cavity of a patient. Access through these percutaneous punctures allows a physician to carry out various procedures in or through the body cavity for examination, surgery, treatment and the like. While not meant to be limiting, the systems are illustrated being used to seal percutaneous punctures that provide access to blood vessels in patients for various procedures. It will be appreciated that the systems are applicable to other procedures requiring sealing of a puncture through body tissue into a cavity including, for example, laparoscopic surgery and other microscopic surgery techniques using a relatively small incision.
  • engage and “engagable” are used broadly to mean interlock, mesh, or contact between two structures or devices. Likewise “disengage” or “disengagable” means to remove or capable of being removed from interlock, mesh, or contact.
  • a “tube” is an elongated device with a passageway. The passageway may be enclosed or open (e.g., a trough).
  • a “lumen” refers to any open space or cavity in a bodily organ, especially in a blood vessel.
  • tissue closure devices used for sealing a tissue puncture in an internal tissue wall accessible through an incision in the skin are known in the art.
  • Applications of closure devices including those implementing principles described herein include closure of a percutaneous puncture or incision in tissue separating two internal portions of a living body, such as punctures or incisions in blood vessels, ducts or lumens, gall bladders, livers, hearts, etc.
  • An exemplary embodiment of the present disclosure includes a vascular closure system used to provide hemostatis of a vessel puncture.
  • the vascular closure system may include a bioadhesive delivery device configured to apply bioadhesive to a previously sutured vessel puncture (e.g., arteriotomy).
  • the bioadhesive may work in conjunction with the suture to maintain hemostatis.
  • the use of a bioadhesive to achieve hemostatis in combination with a suture closure of the vessel puncture may be particularly useful when dealing with large arteriotomies (e.g., 18 French (F) to 24 F).
  • the bioadhesive delivery device may include a syringe loaded with a bioadhesive, and a delivery sheath coupled in flow communication with the syringe for delivery of the bioadhesive to the vessel puncture.
  • the vessel puncture may have been pre-sutured using a separate large bore closure device or other suture placement device.
  • the sutures may be secured using, for example, knots or a suture locking device such as a clip.
  • a distal tip of the delivery sheath may be designed to communicate with the protruding suture to help advance the bioadhesive delivery device down a percutaneous tissue tract to the vessel.
  • the bioadhesive may be applied to help secure the suture and further seal the vessel puncture to provide improved hemostasis.
  • the vascular closure system may be particularly useful as part of closing a large bore tissue puncture.
  • Large bore tissue punctures are typically in the range from about 5 F to about 30 F, and more particularly from 10 F to about 25 F.
  • a suture placement device may be used to place at least one suture through tissue adjacent to the tissue puncture.
  • the suture placement device places two sutures in a wall of the vessel adjacent to the vessel puncture.
  • a suture placement device may be operable percutaneously through a layer of tissue (e.g., skin or fat) that provides access via a tissue tract to the vessel puncture.
  • Suture locking devices or knots may be used to apply and maintain tension in the sutures to at least partially seal the vessel puncture.
  • the free ends of the suture may extend out of the layer of tissue for use in guiding the bioadhesive delivery device to the vessel.
  • the free ends of the suture may be captured by or extend through a portion of the bioadhesive delivery device to provide improved guiding to the vessel puncture.
  • the sealant delivery device may be configured with rapid exchange features that permit mounting the sealant delivery device to the sutures at a location outside of the tissue tract and distal of the proximal ends of the sutures.
  • the free ends of the suture may be cut within the tissue tract after delivery of the bioadhesive and removal of the sealant delivery device.
  • the vascular closure system 10 includes a sealant delivery device 12 and an optional suture placement device 14.
  • the suture placement device 14 may be used to position at least one suture cross a vessel puncture.
  • the suture placement device 14 is removed and the sealant delivery device 12 is advanced along the suture to the vessel puncture.
  • the sealant delivery device 12 deposits a volume of bioadhesive at the vessel puncture.
  • the suture and bioadhesive may be used to seal the vessel puncture and provide hemostatis.
  • a knot or suture locking device may be advanced along the suture to at least partially seal the vessel puncture prior to delivery of the bioadhesive.
  • the sealant delivery device 12 includes a sealant shaft 20 (also referred to as a delivery sheath), a sealant manifold 22, and a sealant mixing device 24.
  • the sealant shaft 20 includes a sealant lumen 26 (see FIGS. 1A) and an exchange lumen 28.
  • the sealant lumen 26 is coupled in flow communication with the sealant mixing device 24 via the sealant manifold 22.
  • the sealant mixing device 24 includes a housing 25 and a plunger 27. Operating the plunger 27 in an axial direction relative to the housing 25 advances the bioadhesive through the sealant manifold 22 and the sealant lumen 26, and out at the vessel puncture.
  • the exchange lumen 28 includes a distal end opening 32, insertion slot 34, a longitudinal guide slot 36, and a tip 44 (see FIG. IB).
  • the tip 44 may define at least in part the distal end opening 32 and the insertion slot 34.
  • the insertion slot 34 may have a contoured shape such as a helical shape.
  • the insertion slot 34 may be referred to as a helical insertion slot. Many other shapes and constructions are possible for the insertion slot 34.
  • the insertion slot 34 permits a suture to be threaded into the longitudinal guide slot 36 at any point along a length of the suture.
  • the insertion slot 34 may extend through approximately 90° as shown in FIG. IB, although the insertion slot 34 may also traverse smaller or larger angles such as 180°.
  • the insertion slot 34 is open to the distal end opening 32 and intersects with the longitudinal guide slot 36.
  • the longitudinal guide slot 36 may be shaped generally like a capsule with the insertion slot 34 intersecting the longitudinal guide slot 36 at a location spaced between its distal and proximal ends 38, 40.
  • the longitudinal guide slot 36 may have a shape and orientation that limits an inserted suture from falling out of the longitudinal guide slot 36.
  • a suture such as the suture 62 shown in FIG. 2A and FIGS. 4-10
  • the suture tends to fall towards the proximal end 40 of the longitudinal guide slot 36, which prevents the suture 62 from slipping back out of the insertion slot 34.
  • the longitudinal guide slot 36 is aligned parallel with the longitudinal axis of the sealant shaft 20.
  • the tip 44 may include various features which assist in advancing the suture 62 into the insertion slot 34.
  • the tip 44 may include tapered features such as a tapered opening at a distal surface thereof or along side surfaces thereof in alignment with the insertion slot 34 to enhance insertion of the suture 62.
  • the tip 44 includes a cantilever arm 42 (see FIGS. 2A-2B).
  • the cantilever arm may act as a one-way opening or door.
  • the suture 62 may deflect the cantilever arm 42 while moving into the insertion slot 34.
  • the cantilever arm 42 may automatically move back into the position of FIGS. 2A-2B to capture the suture 62 within the exchange lumen 28.
  • the cantilever arm 42 may limit movement of the suture 62 out of the exchange lumen 28 while advancing the sealant delivery device 12 along the suture 62 to the vessel puncture.
  • the suture 62 may be removed from the exchange lumen 28 only by retracting the sealant delivery device 12 proximately off a distal end of the suture 62 when the cantilever arm 42 or a similar feature is used to capture the suture 62.
  • the distal end opening 32 into the exchange lumen 28 may have a diameter D (see FIG. 2B), which is large enough to allow a suture to slide freely therethrough.
  • the diameter D may be small enough to prevent any knots tied into the suture (e.g., knot 64 shown in FIG. 2A) or a suture locking device attached to the suture from entering through the tip 44. Consequently, knots such as knot 64 used to hold closed the vessel puncture cannot enter the exchange lumen 28.
  • the diameter D may be no more than approximately two to three times the diameter of the suture 62.
  • the suture has a diameter of about 0.12 mm and the internal diameter D is no more than about 0.35 mm.
  • FIGS. 3A-3C An alternative tip 144 is shown with reference to FIGS. 3A-3C.
  • the tip 144 is mounted to a sealant shaft 120, which includes a sealant lumen 126 and an exchange lumen 128.
  • the tip 144 includes a one-way door 142, which provides access into the exchange lumen 128.
  • the tip 144 may include a taper 146 leading to the one-way door 142.
  • the one-way door 142 may move from a closed position shown in FIG. 3B to an open position shown in FIG. 3C to permit passage of a suture into the exchange lumen 128.
  • the one-way door 142 may automatically return back to the closed position shown in FIG. 3B upon removing the radially directed force applied to the one-way door 142 by the suture when inserting the suture into the exchange lumen 128.
  • the cantilever arm 42 and one-way door 142 described with reference to FIGS. 2A-3C are included as features of the tips 44, 144, respectively.
  • similar suture capturing or locking features may be integrated directly into the sealant shaft 20, 120, rather than being formed in a separate tip, which is inserted into an open distal end of the sealant shaft.
  • additional features may be mounted on an exterior circumferential surface of the sealant shaft to assist in capturing the suture within the exchange lumen 128.
  • the sealant shaft 20 includes the sealant lumen 26, but does not include a separate exchange lumen 28.
  • the sealant shaft 20 may include a feature positioned on an outer surface thereof or at the distal tip thereof, which provides a slideable connection with the suture 62 for purposes of tracking the sealant delivery device along the suture 62 to the vessel puncture.
  • the sealant shaft 20 does not include a side or lateral opening into the exchange lumen 28.
  • the sealant shaft 20 may include a different rapid exchange feature for mounting the sealant delivery device 12 to the suture 62.
  • the rapid exchange feature may make it possible to mount the sealant delivery device 12 to the suture 62 at a location spaced between the proximal and distal ends of the suture 62.
  • the rapid exchange capability may be particularly useful when the suture is relatively long and flexible, making it difficult to thread the suture through the exchange lumen 28 and out of a proximal open end of the sealing shaft (e.g., along an entire length of the sealing shaft 20).
  • the rapid exchange feature includes an exchange lumen 28 open at its distal end 32 and then closed along at least a portion of its length to a location spaced proximal of the distal end opening 32 wherein a lateral opening is formed in the exchange lumen 28.
  • the proximal end of the suture 62 may be threaded through the distal end opening 32 and out of the lateral opening at a location distal of the sealant manifold 22.
  • the sealant mixing device 24 may carry at least one sealant material.
  • the sealant material carried by the sealant mixing device 24 includes at least two components that remain separated until just prior to delivering the sealant material to the vessel puncture.
  • the sealant mixing device 24 is shown having a plunger 27 used to expel the sealant material from the sealant delivery device 12.
  • Other structures and mechanisms may be used to mix, store, and eject the sealant material through the sealant shaft 20 to a tissue puncture.
  • Example sealant mixing devices and related sealant materials are disclosed in U.S. Patent Application No. 61/692,859 filed on 24 August 2012, and entitled “Sealant Storage, Preparation and Delivery Systems and Related Methods," and U.S. Patent Application No. 61/693,052, filed on 24 August 2012, and entitled “Bioadhesive Mixing and Delivery Device and Methods", which patent applications are incorporated herein in their entireties by this reference.
  • the suture placement device 14 shown in FIG. 1 includes a handle 50, and insertion shaft 52, an anchor 54, a suture carrying portion 56, a needle 58, and a distal locator tip 60.
  • the handle 50 may include first and second actuators 66, 68.
  • the suture carrying portion 56 may include a plurality of sutures 62.
  • the suture placement device 14 may be operated to place at least one of the sutures 62 across a vessel puncture 96 as described below with reference to FIGS. 4-10.
  • the first actuator 66 may be operated to move the anchor 54 into an expanded position to capture a vessel wall as shown in FIG. 4.
  • the second actuator 68 may be operated to advance the needles 58 through the vessel wall and into contact with the suture carrying portion 56 to capture the suture 62.
  • the second actuator may be operated in a reverse direction to retract the needles 58 to pull the suture 62 through the vessel wall.
  • the first actuator 66 may be operated in a reverse direction to retract the anchor 54, followed by withdrawal of the suture placement device 14 from the vessel puncture.
  • the suture 62 remains positioned extending through the vessel wall as shown in FIG. 6.
  • suture placement device 14 is used to place at least one suture across the vessel puncture prior to other treatment and operational steps related to closing the vessel puncture.
  • the suture placement device 14 may be operated at shown in FIGS. 4-5 to place the sutures 62 across the vessel puncture prior to advancing the sealant delivery device 12 along the suture 62 to the vessel puncture.
  • FIGS. 4-10 an example method of sealing a vessel puncture using the vascular closure system 10 is described in detail.
  • at least one suture 62 is positioned across a vessel puncture 96 using suture placement device 14.
  • the vessel puncture 96 is formed in vessel 94 and is accessible through a tissue tract 92 of a tissue layer 90.
  • the suture placement device 14 is advanced through the tissue layer 92 and the vessel puncture 96 to position the anchor 54, suture carrying portion 56, and distal locator tip 60 within the vessel lumen 98.
  • the suture placement device 14 is then operated by actuating first actuator 66 to capture a wall of vessel 94 between a distal end surface of the insertion shaft 52 and proximal surfaces of the anchor 54.
  • the second actuator 68 is then actuated to advance needles 58 through the wall of the vessel 94 and into contact with the sutures 62 carried by the suture carrying portion 56.
  • the second actuator 68 is operated in a reverse direction to withdraw the needles 58 and sutures 62 through the vessel wall as shown in FIG. 5.
  • the first actuator 66 is operated in a reverse direction to retract the anchor 54.
  • the suture placement device 14 is then withdrawn from the vessel puncture 96 and tissue tract 92.
  • the suture 62 remains extending across the vessel puncture 96 as shown in FIG. 6. Free ends of the suture 62 may extend out of the tissue layer 90 for handling by the operator.
  • the operator may tie a knot in at least one of the sutures 62 and advance the knot through the tissue tract 92 to the vessel puncture 96.
  • the knot may be used to cinch at least one of the sutures 62 to maintain tension in the suture 62 to close the vessel puncture 96.
  • At least one suture locking device may be used in combination with or in place of the knot 64 for maintaining tension in the suture 62 to hold closed the vessel puncture 96.
  • the suture locking device (not shown) may be advanced along the suture 62 and into the tissue tract 92 to a position adjacent to the vessel puncture 96.
  • closing the vessel puncture 96 using only the sutures 62 and any knots or suture locking devices used therewith may provide an initial closure of the vessel puncture 96 (e.g., preliminary hemostasis).
  • relatively large vessel punctures such as vessel punctures in the range of about 10 F to 30 F (e.g., about 18 F to about 24 F), which are referred to as large bore vessel punctures
  • using sutures alone to close the vessel puncture may be inadequate to provide complete hemostatis.
  • the sealant delivery device 12 may be used in combination with the suture closure shown in FIGS. 4-7 to further seal and maintain closure (e.g., hemostasis) of the vessel puncture 96.
  • the sealant delivery device 12 may be mounted to at least one of the sutures 62.
  • the sutures 62 are positioned within the exchange lumen 28 and oriented within the longitudinal guide slot 36 as shown in FIG. 8.
  • the sealant delivery device 12 is then advanced along the suture 62 to the vessel puncture 96.
  • a sealant shaft and associated tip construction that provides a positive connection between the sealant delivery device 12 and the sutures 62 while permitting relative sliding motion therebetween for guiding the sealant delivery device 12 along the sutures 62 to the vessel puncture.
  • the sutures 62 maintain connection to the sealant shaft using a one-way door (e.g., via doors 42, 142 described above).
  • the sutures 62 are held in the sealant shaft by applying a rotation force to the sealant delivery device 12.
  • the sealant delivery device 12 is operated to advance a volume of sealant through the sealant lumen 26 and into the area surrounding the vessel puncture 96 along an exterior of the vessel 94.
  • the volume of sealant may form a sealant plug 48 that fills at least a portion of the tissue tract 92 and encapsulates at least a portion of the suture 62 and the knot 64.
  • the plug 48 may provide further sealing of the vessel puncture 96.
  • the plug 48 may bond with an outer surface of the vessel 94 adjacent to the vessel puncture 96.
  • the plug 48 may also bond with the tissue layer 90 within the tissue tract 92.
  • the plug 48 may bond directly to the suture 62 to provide a connection therebetween.
  • the plug 48 may provide a secondary seal for the vessel puncture 96 and provide further hemostatis.
  • the sealant delivery device may then be withdrawn along the suture 62 and out of the tissue tract as shown in FIG. 10.
  • the suture 62 may be trimmed to a shorter length.
  • the suture 62 may be cut within the tissue tract 92 at a location below an outer surface of the tissue layer 90.
  • the tissue tract 92 may close around the plug 48.
  • a sealant shaft includes a sealant lumen and an exchange lumen that does not include a side opening.
  • the exchange port may provide a rapid exchange mounting of the sealant delivery device to the sutures.
  • the rapid exchange features may make it possible to mount the sealant delivery device to the sutures at a location spaced between proximal and distal ends of the sutures.
  • the sealant delivered by the vascular closure system 10 may be used in combination with or independent of at least partially sealing vessel puncture 96 with sutures 62 and corresponding suture knots 64 or a suture locking device.
  • Using a combination of sutures and sealing material may be particularly effective in maintaining a sealed closure of a large bore vessel puncture, wherein sutures or sealing material independently may be less effective in maintaining closure of the vessel puncture.
  • the sealants discussed herein may comprise a single component, or may comprise multiple sealant components that are mixed together.
  • the multiple sealant components may further react together to form a crosslinked network.
  • the sealant components may be naturally derived or synthetic.
  • Some example synthetic components include polyethers such as polyethylene glycol, polypropylene glycol and polytetrahydrofuran.
  • Other examples of synthetic components may include polyamine compositions such as polyvinylpyrrolidones, polyethylene imines and hydrogenated polyacrylonitriles.
  • Other example sealant components include polyacrylic and methacrylic compounds such as polyacrylic acid.
  • Example naturally derived components include protienaceous compositions such as albumin, collagen and polylysine.
  • Other examples include carbohydrate compositions such polyhyaluronic acid.
  • the sealant components may also contain reactive functional groups to promote chemical crosslinking.
  • the sealant components may be cross-linked by any known method including, for example, condensation reactions, Michael addition, and free radical.
  • Functional groups used for cross-linking may include, for example, thiols, acrylates, amines, succinimydyls and aldehydes, to name a few.
  • a particularly preferred bioadhesive comprises a two-part aldhehyde plus albumin composition. This composition may have the practical advance of not requiring pre-mixing, is gamma sterilizable, and provides high tissue adhesion.
  • the sealing material includes two separate components that remain separated from each other within the sealant mixing device 24 until delivery.
  • the sealing material includes 20% solids in a 1 : 1 10 mL batch formulation.
  • the first component includes 1.4 g of bovine serum albumin (BSA) and 3.6 mL of polyphenylene sulfide (PPS).
  • the second component includes 25% glutaraldenhyde in the amount of 2.6 mL and an additional 2.5 mL of deionized water.
  • the amount of seeping material ejected at the vessel puncture may vary depending on, for example, the size of the vessel puncture.
  • the total amount of bioadhesive material ejected is in the range of about 0.2 mL to about 1.0 mL, more preferably about 0.4 mL to about 0.6 mL.

Abstract

A vascular closure assembly includes a suture placement device and a sealant delivery device. The suture placement device is operable to position at least one suture across the puncture to form a primary seal of the puncture. The sealant delivery device includes a sealant delivery tube having a first lumen sized to receive the at least one suture, and a second lumen configured to deliver a volume of sealant to the puncture after forming the primary seal to create a secondary seal of the puncture. The sealant delivery device is slidable along the at least one suture to the puncture.

Description

LARGE BORE CLOSURE SECONDARY HEMOSTASIS BIOADHESIVE DELIVERY
SYSTEMS AND METHODS
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to and the benefit of United States non-provisional application no. 13/797,302 filed 12 March 2013, the entire contents of which are hereby incorporated by reference as though fully set forth herein.
TECHNICAL FIELD
[0002] The present disclosure relates generally to methods and systems for sealing tissue punctures, and more particularly, to methods and systems for sealing large bore openings in vessels using multiple closure mechanisms.
BACKGROUND
[0003] Various surgical procedures are routinely carried out intravascularly or intraluminally. For example, in the treatment of vascular disease, such as arteriosclerosis, it is a common practice to access the artery and insert an instrument (e.g., a balloon or other type of catheter) to carry out a procedure within the artery. Such procedures usually involve the percutaneous puncture of the artery so that an insertion sheath may be placed in the artery and thereafter instruments (e.g., catheters) may pass through the sheath to an operative position within the artery. Intravascular and intraluminal procedures unavoidably present the problem of stopping the bleeding at the percutaneous puncture after the procedure has been completed and after the instruments (and any insertion sheaths used therewith) have been removed. Bleeding from puncture sites, particularly in the case of femoral arterial punctures, is typically stopped by utilizing vascular closure devices.
[0004] While there are a variety of prior art devices and techniques for closing such punctures, one method includes temporarily sealing the tissue puncture intravascularly using an inflation balloon. A sealing material may be delivered to an outer surface of the tissue to seal the tissue puncture.
[0005] Closing large bore openings in a vessel may be particularly difficult using a pre-formed or flowable sealing material on an exterior surface of the vessel. Challenges exist related to holding closed a large bore opening using only a sealing material because of the large size of the opening and the natural forces tending to bias the opening away from a closed position. Opportunities exist for improvement in closing large bore openings to improve hemostasis.
SUMMARY
[0006] One aspect of the present disclosure relates to a vascular closure assembly configured to seal an opening or puncture in a vessel. The vascular closure assembly includes a suture placement device and a sealant delivery device. The suture placement device is operable to position at least one suture across the puncture to form a primary seal of the puncture. The sealant delivery device includes a sealant delivery tube having a first lumen sized to receive the at least one suture, and a second lumen configured to deliver a volume of sealant to the puncture after forming the primary seal to create a secondary seal of the puncture. The sealant delivery device is slidable along the at least one suture to the puncture.
[0007] The sealant delivery tube may include a suture insertion slot at a distal end of the sealant delivery tube. The sealant delivery tube may include a helical shaped suture insertion slot at a distal end thereof, and a longitudinal guide slot open to the helical shaped suture insertion slot. The sealant delivery tube may include a helical shaped suture insertion slot at a distal end thereof, wherein the insertion slot forms an acute angle along its length. The sealant delivery device may include a suture retaining member positioned at a distal end thereof, wherein the suture retaining member permits one-way insertion of the at least one suture into the first lumen. The suture placement device may position the at least one suture on opposite sides of the puncture, and tension may be retained in the at least one suture with one of a knot and a suture locking device to at least partially seal the puncture prior to delivering the volume of sealant.
[0008] Another aspect of the present disclosure relates to a method of closing a puncture in a vessel. The method includes providing a suture placement device and a sealant delivery device, positioning at least one suture across the puncture with the suture placement device, sealing the puncture with the at least one suture, advancing the sealant delivery device along the at least one suture to the puncture, and delivering a volume of sealant through the sealant delivery device to the puncture to further seal the puncture.
[0009] The method may also include providing a releasable connection between the sealant delivery device and the at least one suture. Delivering a volume of sealant may include mixing the volume of sealant in the sealant delivery device during delivery. The sealant delivery device may include a first lumen configured to receive the at least one suture and a second lumen configured to deliver the volume of sealant. Sealing the puncture may include advancing a knot along the at least one suture to the puncture. The at least one suture may include two suture portions and the sealant delivery device may be advanced along both suture portions to the puncture.
[0010] The sealant delivery device may include a sealant shaft and an insertion slot extending proximally from an open distal end of the sealant shaft, and the method may include inserting the at least one suture into the insertion slot prior to advancing the sealant delivery device. The sealant delivery device may include a guide slot spaced proximal of the open distal end and intersecting with the insertion slot, and the method may include inserting the at least one suture through the insertion slot and into the guide slot prior to advancing the sealant delivery device. The method may include inserting the at least one suture into a portion of the sealant delivery device before advancing the sealant delivery device.
[0011] Another example method in accordance with the present disclosure relates to sealing a puncture in a vessel accessible through a percutaneous incision. The method includes providing a sealant delivery device having first and second lumens, and a suture placement device, positioning at least one suture across the puncture with the suture placement device, advancing a knot along the at least one suture to seal the puncture, positioning the at least one suture in the first lumen, advancing the sealant delivery device along the at least one suture to the puncture, and delivering a volume of sealant through the second lumen to the puncture to seal the puncture.
[0012] The sealant delivery device may include a helical shaped insertion slot providing lateral access into the first lumen, and positioning the at least one suture in the first lumen includes laterally inserting the at least one suture through the insertion slot. The sealant delivery device may include a guide slot intersecting the insertion slot and extending longitudinally, and positioning the at least one suture in the first lumen includes positioning the at least one suture in the guide slot. The sealant may include a resorbable bioadhesive. Positioning at least one suture across the puncture with the suture placement device may include inserting the suture placement device in the puncture, advancing at least one needle through a wall of the vessel adjacent to the puncture, drawing the at least one suture through the wall of the vessel, and removing the suture placement device from the puncture.
[0013] The foregoing and other features, utilities, and advantages of the invention will be apparent from the following detailed description of the invention with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The accompanying drawings illustrate various embodiments of the present disclosure and are a part of the specification. The illustrated embodiments are merely examples of the present disclosure and do not limit the scope of the invention.
[0015] FIG. 1 shows components of an example vascular closure system in accordance with the present disclosure.
[0016] FIG. 1A is a cross-sectional view of a sealant delivery device of the vascular closure system shown in FIG. 1 taken along cross-sectional indicators 1A-1A.
[0017] FIG. IB is a close-up view of a distal end portion of the sealant delivery device of the vascular closure system of FIG. 1.
[0018] FIG. 2A is a close-up view of a distal end portion of another example sealant delivery device.
[0019] FIG. 2B is an end view of the sealant delivery device of FIG. 2A.
[0020] FIG. 3A is a close-up view of a distal end portion of another example sealant delivery device.
[0021] FIG. 3B is an end view of the sealant delivery device of FIG. 3A in a closed position.
[0022] FIG. 3 C is an end view of the sealant delivery device of FIG. 3 A in an open position.
[0023] FIGS. 4-10 show steps of an example method of sealing a vessel puncture using the vascular closure system of FIG. 1.
[0024] Throughout the drawings, identical reference numbers designate similar, but not necessarily identical, elements.
DETAILED DESCRIPTION
[0025] The systems disclosed herein may be used to close or seal percutaneous punctures made through the body tissue of a patient to gain access to a body cavity of a patient. Access through these percutaneous punctures allows a physician to carry out various procedures in or through the body cavity for examination, surgery, treatment and the like. While not meant to be limiting, the systems are illustrated being used to seal percutaneous punctures that provide access to blood vessels in patients for various procedures. It will be appreciated that the systems are applicable to other procedures requiring sealing of a puncture through body tissue into a cavity including, for example, laparoscopic surgery and other microscopic surgery techniques using a relatively small incision. [0026] As used in this specification and the appended claims, the terms "engage" and "engagable" are used broadly to mean interlock, mesh, or contact between two structures or devices. Likewise "disengage" or "disengagable" means to remove or capable of being removed from interlock, mesh, or contact. A "tube" is an elongated device with a passageway. The passageway may be enclosed or open (e.g., a trough). A "lumen" refers to any open space or cavity in a bodily organ, especially in a blood vessel. The words "including" and "having," as well as their derivatives, as used in the specification, including the claims, have the same meaning as the word "comprising."
[0027] The general structure and function of tissue closure devices used for sealing a tissue puncture in an internal tissue wall accessible through an incision in the skin are known in the art. Applications of closure devices including those implementing principles described herein include closure of a percutaneous puncture or incision in tissue separating two internal portions of a living body, such as punctures or incisions in blood vessels, ducts or lumens, gall bladders, livers, hearts, etc.
[0028] An exemplary embodiment of the present disclosure includes a vascular closure system used to provide hemostatis of a vessel puncture. One aspect of the present disclosure relates to systems and methods for achieving secondary hemostatis of a vessel puncture that has been closed using at least one suture. The vascular closure system may include a bioadhesive delivery device configured to apply bioadhesive to a previously sutured vessel puncture (e.g., arteriotomy). The bioadhesive may work in conjunction with the suture to maintain hemostatis. The use of a bioadhesive to achieve hemostatis in combination with a suture closure of the vessel puncture may be particularly useful when dealing with large arteriotomies (e.g., 18 French (F) to 24 F).
[0029] The bioadhesive delivery device may include a syringe loaded with a bioadhesive, and a delivery sheath coupled in flow communication with the syringe for delivery of the bioadhesive to the vessel puncture. For the procedure, the vessel puncture may have been pre-sutured using a separate large bore closure device or other suture placement device. The sutures may be secured using, for example, knots or a suture locking device such as a clip. A distal tip of the delivery sheath may be designed to communicate with the protruding suture to help advance the bioadhesive delivery device down a percutaneous tissue tract to the vessel. The bioadhesive may be applied to help secure the suture and further seal the vessel puncture to provide improved hemostasis.
[0030] As mentioned above, the vascular closure system may be particularly useful as part of closing a large bore tissue puncture. Large bore tissue punctures are typically in the range from about 5 F to about 30 F, and more particularly from 10 F to about 25 F. A suture placement device may be used to place at least one suture through tissue adjacent to the tissue puncture. In one example, the suture placement device places two sutures in a wall of the vessel adjacent to the vessel puncture. A suture placement device may be operable percutaneously through a layer of tissue (e.g., skin or fat) that provides access via a tissue tract to the vessel puncture.
[0031] Suture locking devices or knots may be used to apply and maintain tension in the sutures to at least partially seal the vessel puncture. The free ends of the suture may extend out of the layer of tissue for use in guiding the bioadhesive delivery device to the vessel. The free ends of the suture may be captured by or extend through a portion of the bioadhesive delivery device to provide improved guiding to the vessel puncture. The sealant delivery device may be configured with rapid exchange features that permit mounting the sealant delivery device to the sutures at a location outside of the tissue tract and distal of the proximal ends of the sutures. The free ends of the suture may be cut within the tissue tract after delivery of the bioadhesive and removal of the sealant delivery device.
[0032] Referring now to FIG. 1, an example vascular closure system 10 (also referred to as a vascular closure assembly) is shown and described. The vascular closure system 10 includes a sealant delivery device 12 and an optional suture placement device 14. The suture placement device 14 may be used to position at least one suture cross a vessel puncture. The suture placement device 14 is removed and the sealant delivery device 12 is advanced along the suture to the vessel puncture. The sealant delivery device 12 deposits a volume of bioadhesive at the vessel puncture. The suture and bioadhesive may be used to seal the vessel puncture and provide hemostatis. A knot or suture locking device may be advanced along the suture to at least partially seal the vessel puncture prior to delivery of the bioadhesive.
[0033] Referring now to FIGS. 1-lB, the sealant delivery device 12 includes a sealant shaft 20 (also referred to as a delivery sheath), a sealant manifold 22, and a sealant mixing device 24. The sealant shaft 20 includes a sealant lumen 26 (see FIGS. 1A) and an exchange lumen 28. The sealant lumen 26 is coupled in flow communication with the sealant mixing device 24 via the sealant manifold 22. The sealant mixing device 24 includes a housing 25 and a plunger 27. Operating the plunger 27 in an axial direction relative to the housing 25 advances the bioadhesive through the sealant manifold 22 and the sealant lumen 26, and out at the vessel puncture. [0034] The exchange lumen 28 includes a distal end opening 32, insertion slot 34, a longitudinal guide slot 36, and a tip 44 (see FIG. IB). The tip 44 may define at least in part the distal end opening 32 and the insertion slot 34. The insertion slot 34 may have a contoured shape such as a helical shape. The insertion slot 34 may be referred to as a helical insertion slot. Many other shapes and constructions are possible for the insertion slot 34. The insertion slot 34 permits a suture to be threaded into the longitudinal guide slot 36 at any point along a length of the suture. The insertion slot 34 may extend through approximately 90° as shown in FIG. IB, although the insertion slot 34 may also traverse smaller or larger angles such as 180°. The insertion slot 34 is open to the distal end opening 32 and intersects with the longitudinal guide slot 36.
[0035] The longitudinal guide slot 36 may be shaped generally like a capsule with the insertion slot 34 intersecting the longitudinal guide slot 36 at a location spaced between its distal and proximal ends 38, 40. The longitudinal guide slot 36 may have a shape and orientation that limits an inserted suture from falling out of the longitudinal guide slot 36. As a suture, such as the suture 62 shown in FIG. 2A and FIGS. 4-10, is threaded into the insertion slot 34 and longitudinal guide slot 36, the suture tends to fall towards the proximal end 40 of the longitudinal guide slot 36, which prevents the suture 62 from slipping back out of the insertion slot 34. In at least one example, the longitudinal guide slot 36 is aligned parallel with the longitudinal axis of the sealant shaft 20.
[0036] The tip 44 may include various features which assist in advancing the suture 62 into the insertion slot 34. The tip 44 may include tapered features such as a tapered opening at a distal surface thereof or along side surfaces thereof in alignment with the insertion slot 34 to enhance insertion of the suture 62. In one example, the tip 44 includes a cantilever arm 42 (see FIGS. 2A-2B). The cantilever arm may act as a one-way opening or door. The suture 62 may deflect the cantilever arm 42 while moving into the insertion slot 34. The cantilever arm 42 may automatically move back into the position of FIGS. 2A-2B to capture the suture 62 within the exchange lumen 28. The cantilever arm 42 may limit movement of the suture 62 out of the exchange lumen 28 while advancing the sealant delivery device 12 along the suture 62 to the vessel puncture. In one example, the suture 62 may be removed from the exchange lumen 28 only by retracting the sealant delivery device 12 proximately off a distal end of the suture 62 when the cantilever arm 42 or a similar feature is used to capture the suture 62.
[0037] The distal end opening 32 into the exchange lumen 28 may have a diameter D (see FIG. 2B), which is large enough to allow a suture to slide freely therethrough. The diameter D may be small enough to prevent any knots tied into the suture (e.g., knot 64 shown in FIG. 2A) or a suture locking device attached to the suture from entering through the tip 44. Consequently, knots such as knot 64 used to hold closed the vessel puncture cannot enter the exchange lumen 28. In some examples, the diameter D may be no more than approximately two to three times the diameter of the suture 62. In one example, the suture has a diameter of about 0.12 mm and the internal diameter D is no more than about 0.35 mm.
[0038] An alternative tip 144 is shown with reference to FIGS. 3A-3C. The tip 144 is mounted to a sealant shaft 120, which includes a sealant lumen 126 and an exchange lumen 128. The tip 144 includes a one-way door 142, which provides access into the exchange lumen 128. The tip 144 may include a taper 146 leading to the one-way door 142. The one-way door 142 may move from a closed position shown in FIG. 3B to an open position shown in FIG. 3C to permit passage of a suture into the exchange lumen 128. The one-way door 142 may automatically return back to the closed position shown in FIG. 3B upon removing the radially directed force applied to the one-way door 142 by the suture when inserting the suture into the exchange lumen 128.
[0039] The cantilever arm 42 and one-way door 142 described with reference to FIGS. 2A-3C are included as features of the tips 44, 144, respectively. In other examples, similar suture capturing or locking features may be integrated directly into the sealant shaft 20, 120, rather than being formed in a separate tip, which is inserted into an open distal end of the sealant shaft. In alternative configurations, additional features may be mounted on an exterior circumferential surface of the sealant shaft to assist in capturing the suture within the exchange lumen 128. In still further embodiments, the sealant shaft 20 includes the sealant lumen 26, but does not include a separate exchange lumen 28. The sealant shaft 20 may include a feature positioned on an outer surface thereof or at the distal tip thereof, which provides a slideable connection with the suture 62 for purposes of tracking the sealant delivery device along the suture 62 to the vessel puncture.
[0040] In other arrangements, the sealant shaft 20 does not include a side or lateral opening into the exchange lumen 28. The sealant shaft 20 may include a different rapid exchange feature for mounting the sealant delivery device 12 to the suture 62. The rapid exchange feature may make it possible to mount the sealant delivery device 12 to the suture 62 at a location spaced between the proximal and distal ends of the suture 62. The rapid exchange capability may be particularly useful when the suture is relatively long and flexible, making it difficult to thread the suture through the exchange lumen 28 and out of a proximal open end of the sealing shaft (e.g., along an entire length of the sealing shaft 20). In some arrangements, the rapid exchange feature includes an exchange lumen 28 open at its distal end 32 and then closed along at least a portion of its length to a location spaced proximal of the distal end opening 32 wherein a lateral opening is formed in the exchange lumen 28. The proximal end of the suture 62 may be threaded through the distal end opening 32 and out of the lateral opening at a location distal of the sealant manifold 22.
[0041] The sealant mixing device 24 may carry at least one sealant material. In one example, the sealant material carried by the sealant mixing device 24 includes at least two components that remain separated until just prior to delivering the sealant material to the vessel puncture. The sealant mixing device 24 is shown having a plunger 27 used to expel the sealant material from the sealant delivery device 12. Other structures and mechanisms may be used to mix, store, and eject the sealant material through the sealant shaft 20 to a tissue puncture. Example sealant mixing devices and related sealant materials are disclosed in U.S. Patent Application No. 61/692,859 filed on 24 August 2012, and entitled "Sealant Storage, Preparation and Delivery Systems and Related Methods," and U.S. Patent Application No. 61/693,052, filed on 24 August 2012, and entitled "Bioadhesive Mixing and Delivery Device and Methods", which patent applications are incorporated herein in their entireties by this reference.
[0042] The suture placement device 14 shown in FIG. 1 includes a handle 50, and insertion shaft 52, an anchor 54, a suture carrying portion 56, a needle 58, and a distal locator tip 60. The handle 50 may include first and second actuators 66, 68. The suture carrying portion 56 may include a plurality of sutures 62. The suture placement device 14 may be operated to place at least one of the sutures 62 across a vessel puncture 96 as described below with reference to FIGS. 4-10. The first actuator 66 may be operated to move the anchor 54 into an expanded position to capture a vessel wall as shown in FIG. 4. The second actuator 68 may be operated to advance the needles 58 through the vessel wall and into contact with the suture carrying portion 56 to capture the suture 62. The second actuator may be operated in a reverse direction to retract the needles 58 to pull the suture 62 through the vessel wall. The first actuator 66 may be operated in a reverse direction to retract the anchor 54, followed by withdrawal of the suture placement device 14 from the vessel puncture. The suture 62 remains positioned extending through the vessel wall as shown in FIG. 6.
[0043] Details concerning operation of an example suture placement device are shown and described in U.S. Patent Application No. 13/490,816, filed on 7 June 2012, and entitled "Large Bore Puncture Closure Device and Methods", which is incorporated herein in its entirety by this reference. Many types of suture placement devices may be used to position at least one suture across the vessel puncture. Typically, the suture placement device 14 is used to place at least one suture across the vessel puncture prior to other treatment and operational steps related to closing the vessel puncture. For example, the suture placement device 14 may be operated at shown in FIGS. 4-5 to place the sutures 62 across the vessel puncture prior to advancing the sealant delivery device 12 along the suture 62 to the vessel puncture.
[0044] Referring now to FIGS. 4-10, an example method of sealing a vessel puncture using the vascular closure system 10 is described in detail. Referring first to FIG. 4, at least one suture 62 is positioned across a vessel puncture 96 using suture placement device 14. The vessel puncture 96 is formed in vessel 94 and is accessible through a tissue tract 92 of a tissue layer 90.
[0045] The suture placement device 14 is advanced through the tissue layer 92 and the vessel puncture 96 to position the anchor 54, suture carrying portion 56, and distal locator tip 60 within the vessel lumen 98. The suture placement device 14 is then operated by actuating first actuator 66 to capture a wall of vessel 94 between a distal end surface of the insertion shaft 52 and proximal surfaces of the anchor 54. The second actuator 68 is then actuated to advance needles 58 through the wall of the vessel 94 and into contact with the sutures 62 carried by the suture carrying portion 56. The second actuator 68 is operated in a reverse direction to withdraw the needles 58 and sutures 62 through the vessel wall as shown in FIG. 5. The first actuator 66 is operated in a reverse direction to retract the anchor 54. The suture placement device 14 is then withdrawn from the vessel puncture 96 and tissue tract 92. The suture 62 remains extending across the vessel puncture 96 as shown in FIG. 6. Free ends of the suture 62 may extend out of the tissue layer 90 for handling by the operator.
[0046] The operator may tie a knot in at least one of the sutures 62 and advance the knot through the tissue tract 92 to the vessel puncture 96. The knot may be used to cinch at least one of the sutures 62 to maintain tension in the suture 62 to close the vessel puncture 96. At least one suture locking device may be used in combination with or in place of the knot 64 for maintaining tension in the suture 62 to hold closed the vessel puncture 96. The suture locking device (not shown) may be advanced along the suture 62 and into the tissue tract 92 to a position adjacent to the vessel puncture 96.
[0047] As discussed above, closing the vessel puncture 96 using only the sutures 62 and any knots or suture locking devices used therewith may provide an initial closure of the vessel puncture 96 (e.g., preliminary hemostasis). However, when closing relatively large vessel punctures such as vessel punctures in the range of about 10 F to 30 F (e.g., about 18 F to about 24 F), which are referred to as large bore vessel punctures, using sutures alone to close the vessel puncture may be inadequate to provide complete hemostatis. The sealant delivery device 12 may be used in combination with the suture closure shown in FIGS. 4-7 to further seal and maintain closure (e.g., hemostasis) of the vessel puncture 96.
[0048] Referring to FIG. 8, the sealant delivery device 12 may be mounted to at least one of the sutures 62. In one example, the sutures 62 are positioned within the exchange lumen 28 and oriented within the longitudinal guide slot 36 as shown in FIG. 8. The sealant delivery device 12 is then advanced along the suture 62 to the vessel puncture 96. As mentioned above, there may be numerous ways to provide a connection between the sealant delivery device 12 and the suture 62 to assist in tracking or guiding the sealant delivery device 12 to the vessel puncture. The exchange lumen 28 shown in FIGS. 8 and 9 and described above is merely one example of a sealant shaft and associated tip construction that provides a positive connection between the sealant delivery device 12 and the sutures 62 while permitting relative sliding motion therebetween for guiding the sealant delivery device 12 along the sutures 62 to the vessel puncture. In one example, the sutures 62 maintain connection to the sealant shaft using a one-way door (e.g., via doors 42, 142 described above). In other examples, the sutures 62 are held in the sealant shaft by applying a rotation force to the sealant delivery device 12.
[0049] Referring to FIG. 9, the sealant delivery device 12 is operated to advance a volume of sealant through the sealant lumen 26 and into the area surrounding the vessel puncture 96 along an exterior of the vessel 94. The volume of sealant may form a sealant plug 48 that fills at least a portion of the tissue tract 92 and encapsulates at least a portion of the suture 62 and the knot 64. The plug 48 may provide further sealing of the vessel puncture 96. The plug 48 may bond with an outer surface of the vessel 94 adjacent to the vessel puncture 96. The plug 48 may also bond with the tissue layer 90 within the tissue tract 92. The plug 48 may bond directly to the suture 62 to provide a connection therebetween. The plug 48 may provide a secondary seal for the vessel puncture 96 and provide further hemostatis.
[0050] The sealant delivery device may then be withdrawn along the suture 62 and out of the tissue tract as shown in FIG. 10. The suture 62 may be trimmed to a shorter length. In at least one example, the suture 62 may be cut within the tissue tract 92 at a location below an outer surface of the tissue layer 90. The tissue tract 92 may close around the plug 48.
[0051] In other arrangements, a sealant shaft includes a sealant lumen and an exchange lumen that does not include a side opening. The exchange port may provide a rapid exchange mounting of the sealant delivery device to the sutures. The rapid exchange features may make it possible to mount the sealant delivery device to the sutures at a location spaced between proximal and distal ends of the sutures.
[0052] The sealant delivered by the vascular closure system 10 may be used in combination with or independent of at least partially sealing vessel puncture 96 with sutures 62 and corresponding suture knots 64 or a suture locking device. Using a combination of sutures and sealing material may be particularly effective in maintaining a sealed closure of a large bore vessel puncture, wherein sutures or sealing material independently may be less effective in maintaining closure of the vessel puncture.
[0053] The sealants discussed herein may comprise a single component, or may comprise multiple sealant components that are mixed together. The multiple sealant components may further react together to form a crosslinked network. The sealant components may be naturally derived or synthetic. Some example synthetic components include polyethers such as polyethylene glycol, polypropylene glycol and polytetrahydrofuran. Other examples of synthetic components may include polyamine compositions such as polyvinylpyrrolidones, polyethylene imines and hydrogenated polyacrylonitriles. Other example sealant components include polyacrylic and methacrylic compounds such as polyacrylic acid. Example naturally derived components include protienaceous compositions such as albumin, collagen and polylysine. Other examples include carbohydrate compositions such polyhyaluronic acid. The sealant components may also contain reactive functional groups to promote chemical crosslinking. The sealant components may be cross-linked by any known method including, for example, condensation reactions, Michael addition, and free radical. Functional groups used for cross-linking may include, for example, thiols, acrylates, amines, succinimydyls and aldehydes, to name a few. A particularly preferred bioadhesive comprises a two-part aldhehyde plus albumin composition. This composition may have the practical advance of not requiring pre-mixing, is gamma sterilizable, and provides high tissue adhesion.
[0054] In one example, the sealing material includes two separate components that remain separated from each other within the sealant mixing device 24 until delivery. In one example, the sealing material includes 20% solids in a 1 : 1 10 mL batch formulation. The first component includes 1.4 g of bovine serum albumin (BSA) and 3.6 mL of polyphenylene sulfide (PPS). The second component includes 25% glutaraldenhyde in the amount of 2.6 mL and an additional 2.5 mL of deionized water. The amount of seeping material ejected at the vessel puncture may vary depending on, for example, the size of the vessel puncture. In one example, the total amount of bioadhesive material ejected is in the range of about 0.2 mL to about 1.0 mL, more preferably about 0.4 mL to about 0.6 mL.
[0055] The preceding description has been presented only to illustrate and describe exemplary embodiments of the invention. It is not intended to be exhaustive or to limit the invention to any precise form disclosed. Many modifications and variations are possible in light of the above teaching. It is intended that the scope of the invention be defined by the following claims.

Claims

WHAT IS CLAIMED IS:
1. A vascular closure assembly configured to seal a puncture in a vessel, comprising:
a suture placement device operable to position at least one suture across the puncture to form a primary seal of the puncture;
a sealant delivery device comprising a sealant delivery tube having a first lumen sized to receive the at least one suture, the sealant delivery device being slidable along the at least one suture to the puncture, and a second lumen configured to deliver a volume of sealant to the puncture after forming the primary seal to create a secondary seal of the puncture.
2. The vascular closure assembly of claim 1, wherein the sealant delivery tube comprises a suture insertion slot at a distal end of the sealant delivery tube.
3. The vascular closure assembly of claim 1, wherein the sealant delivery tube comprises:
a helical shaped suture insertion slot at a distal end thereof;
a longitudinal guide slot open to the helical shaped suture insertion slot.
4. The vascular closure assembly of claim 1, wherein the sealant delivery tube comprises a helical shaped suture insertion slot at a distal end thereof, the insertion slot forming an acute angle.
5. The vascular closure assembly of claim 1, wherein the sealant delivery device comprises a suture retaining member positioned at a distal end thereof, the suture retaining member configured to permit one-way insertion of the at least one suture into the first lumen.
6. The vascular closure assembly of claim 1, wherein the suture placement device positions the at least one suture on opposite sides of the puncture, and tension is retained in the at least one suture with one of a knot and a suture locking device to at least partially seal the puncture prior to delivering the volume of sealant.
7. A method of closing a puncture in a vessel, comprising:
providing a suture placement device and a sealant delivery device; positioning at least one suture across the puncture with the suture placement device; sealing the puncture with the at least one suture;
advancing the sealant delivery device along the at least one suture to the puncture; delivering a volume of sealant through the sealant delivery device to the puncture to further seal the puncture.
8. The method of claim 7, further comprising providing a releasable connection between the sealant delivery device and the at least one suture.
9. The method of claim 7, wherein delivering a volume of sealant includes mixing the volume of sealant in the sealant delivery device during delivery.
10. The method of claim 7, wherein the sealant delivery device comprises a first lumen configured to receive the at least one suture and a second lumen configured to deliver the volume of sealant.
1 1. The method of claim 7, wherein sealing the puncture comprises advancing a knot along the at least one suture to the puncture.
12. The method of claim 7, wherein the at least one suture comprises two suture portions and the sealant delivery device is advanced along both suture portions to the puncture.
13. The method of claim 7, wherein the sealant delivery device comprises a sealant shaft and an insertion slot extending proximally from an open distal end of the sealant shaft, the method comprising inserting the at least one suture into the insertion slot prior to advancing the sealant delivery device.
14. The method of claim 13, wherein the sealant delivery device comprises a guide slot spaced proximal of the open distal end and intersecting with the insertion slot, the method comprising inserting the at least one suture through the insertion slot and into the guide slot prior to advancing the sealant delivery device.
15. The method of claim 7, further comprising inserting the at least one suture into a portion of the sealant delivery device before advancing the sealant delivery device.
16. A method of sealing a puncture in a vessel accessible through a percutaneous incision, the method comprising:
providing a sealant delivery device having first and second lumens, and a suture placement device;
positioning at least one suture across the puncture with the suture placement device; advancing a knot along the at least one suture to seal the puncture;
positioning the at least one suture in the first lumen;
advancing the sealant delivery device along the at least one suture to the puncture; delivering a volume of sealant through the second lumen to the puncture to seal the puncture.
17. The method of claim 16, wherein the sealant delivery device includes a helical shaped insertion slot providing lateral access into the first lumen, and positioning the at least one suture in the first lumen includes laterally inserting the at least one suture through the insertion slot.
18. The method of claim 17, wherein the sealant delivery device includes a guide slot intersecting the insertion slot and extending longitudinally, and positioning the at least one suture in the first lumen includes positioning the at least one suture in the guide slot.
19. The method of claim 16, wherein the sealant comprises a resorbable bioadhesive.
20. The method of claim 16, wherein positioning at least one suture across the puncture with the suture placement device includes inserting the suture placement device in the puncture, advancing at least one needle through a wall of the vessel adjacent to the puncture, drawing the at least one suture through the wall of the vessel, and removing the suture placement device from the puncture.
PCT/US2014/019808 2013-03-12 2014-03-03 Large bore closure secondary hemostasis bioadhesive delivery systems and methods WO2014158747A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14772819.0A EP2967565B1 (en) 2013-03-12 2014-03-03 Large bore closure secondary hemostasis bioadhesive delivery systems and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/797,302 US9055933B2 (en) 2013-03-12 2013-03-12 Large bore closure secondary hemostasis bioadhesive delivery systems and methods
US13/797,302 2013-03-12

Publications (1)

Publication Number Publication Date
WO2014158747A1 true WO2014158747A1 (en) 2014-10-02

Family

ID=51531021

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/019808 WO2014158747A1 (en) 2013-03-12 2014-03-03 Large bore closure secondary hemostasis bioadhesive delivery systems and methods

Country Status (3)

Country Link
US (1) US9055933B2 (en)
EP (1) EP2967565B1 (en)
WO (1) WO2014158747A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3459469A1 (en) 2017-09-23 2019-03-27 Universität Zürich Medical occluder device
US11413427B2 (en) 2018-02-08 2022-08-16 Pacesetter, Inc. Introducer hub assembly having cross-slit seal
BR112021012594A2 (en) * 2018-12-27 2021-09-08 Jose Antonio Pacheco Dos Santos Dias GUIDE WIRE SURGICAL NEEDLE AND KIT
EP4033999A2 (en) 2019-09-26 2022-08-03 Universität Zürich Left atrial appendage occlusion devices
CN115252039B (en) * 2022-09-28 2023-03-10 苏州美创医疗科技有限公司 Vascular closure device and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5810851A (en) * 1996-03-05 1998-09-22 Yoon; Inbae Suture spring device
US20080215088A1 (en) 1998-11-06 2008-09-04 Neomend, Inc. Systems, Methods, and compositions for achieving closure of suture sites
US20080221616A1 (en) * 2000-01-05 2008-09-11 Integrated Vascular Systems, Inc. Integrated vascular device with puncture site closure component and sealant and methods of use
US20090054926A1 (en) * 2007-08-21 2009-02-26 St. Jude Medical Puerto Rico B.V. Extra-vascular sealing device and method
US20100185216A1 (en) * 2008-08-13 2010-07-22 Garrison Michi E Suture delivery device

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470875A (en) 1966-10-06 1969-10-07 Alfred A Johnson Surgical clamping and suturing instrument
US4890612A (en) * 1987-02-17 1990-01-02 Kensey Nash Corporation Device for sealing percutaneous puncture in a vessel
US5304184A (en) 1992-10-19 1994-04-19 Indiana University Foundation Apparatus and method for positive closure of an internal tissue membrane opening
US6036699A (en) 1992-12-10 2000-03-14 Perclose, Inc. Device and method for suturing tissue
US6355050B1 (en) 1992-12-10 2002-03-12 Abbott Laboratories Device and method for suturing tissue
US5417699A (en) 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5431666A (en) 1994-02-24 1995-07-11 Lasersurge, Inc. Surgical suture instrument
US5520702A (en) 1994-02-24 1996-05-28 United States Surgical Corporation Method and apparatus for applying a cinch member to the ends of a suture
US5549633A (en) 1994-08-24 1996-08-27 Kensey Nash Corporation Apparatus and methods of use for preventing blood seepage at a percutaneous puncture site
US5562685A (en) 1994-09-16 1996-10-08 General Surgical Innovations, Inc. Surgical instrument for placing suture or fasteners
US5643292A (en) 1995-01-10 1997-07-01 Applied Medical Resources Corporation Percutaneous suturing device
US5649959A (en) * 1995-02-10 1997-07-22 Sherwood Medical Company Assembly for sealing a puncture in a vessel
US5562686A (en) 1995-04-19 1996-10-08 United States Surgical Corporation Apparaus and method for suturing body tissue
US5700273A (en) 1995-07-14 1997-12-23 C.R. Bard, Inc. Wound closure apparatus and method
US6562052B2 (en) 1995-08-24 2003-05-13 Sutura, Inc. Suturing device and method
WO1997007745A1 (en) 1995-08-24 1997-03-06 Nobles-Lai Engineering, Inc. Method and apparatus for suturing
US5674231A (en) 1995-10-20 1997-10-07 United States Surgical Corporation Apparatus and method for vascular hole closure
US5728133A (en) 1996-07-09 1998-03-17 Cardiologics, L.L.C. Anchoring device and method for sealing percutaneous punctures in vessels
US5766183A (en) 1996-10-21 1998-06-16 Lasersurge, Inc. Vascular hole closure
US6059800A (en) 1997-09-10 2000-05-09 Applied Medical Resources Corporation Suturing apparatus and method
US5972005A (en) 1998-02-17 1999-10-26 Advanced Cardiovascular Systems, Ind. Wound closure assembly and method of use
US6048357A (en) 1998-07-09 2000-04-11 X-Site, L.L.C. Anchoring device and method for sealing punctures in vessels
US20040092964A1 (en) 1999-03-04 2004-05-13 Modesitt D. Bruce Articulating suturing device and method
US7235087B2 (en) 1999-03-04 2007-06-26 Abbott Park Articulating suturing device and method
US7001400B1 (en) 1999-03-04 2006-02-21 Abbott Laboratories Articulating suturing device and method
US6136010A (en) 1999-03-04 2000-10-24 Perclose, Inc. Articulating suturing device and method
US6964668B2 (en) 1999-03-04 2005-11-15 Abbott Laboratories Articulating suturing device and method
US7842048B2 (en) 2006-08-18 2010-11-30 Abbott Laboratories Articulating suture device and method
WO2000078226A1 (en) 1999-06-18 2000-12-28 Radi Medical Systems Ab A tool, a sealing device, a system and a method for closing a wound
AU6059200A (en) 1999-07-02 2001-01-22 Quickpass, Inc. Suturing device
US6641592B1 (en) 1999-11-19 2003-11-04 Lsi Solutions, Inc. System for wound closure
WO2001095809A1 (en) 2000-06-14 2001-12-20 Sterilis, Inc. Suturing method and apparatus
US6890343B2 (en) 2000-12-14 2005-05-10 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US6969397B2 (en) 2000-12-14 2005-11-29 Ensure Medical, Inc. Guide wire element for positioning vascular closure devices and methods for use
US8083768B2 (en) 2000-12-14 2011-12-27 Ensure Medical, Inc. Vascular plug having composite construction
US6623509B2 (en) 2000-12-14 2003-09-23 Core Medical, Inc. Apparatus and methods for sealing vascular punctures
US6896692B2 (en) 2000-12-14 2005-05-24 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US20050267495A1 (en) 2004-05-17 2005-12-01 Gateway Medical, Inc. Systems and methods for closing internal tissue defects
JP2005534388A (en) * 2002-08-01 2005-11-17 アボット ラボラトリーズ バスキュラー エンタープライゼズ リミテッド Self trauma seal device
US7331979B2 (en) 2003-06-04 2008-02-19 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US7361183B2 (en) 2003-10-17 2008-04-22 Ensure Medical, Inc. Locator and delivery device and method of use
US8852229B2 (en) 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
US7621937B2 (en) 2003-12-03 2009-11-24 St. Jude Medical Puerto Rico LC Vascular sealing device with high surface area sealing plug
US7731726B2 (en) 2003-12-03 2010-06-08 St. Jude Medical Puerto Rico Llc Suture based vascular closure apparatus and method incorporating a pre-tied knot
US7390328B2 (en) 2003-12-19 2008-06-24 Abbott Laboratories Device and method for suturing of internal puncture sites
US6932824B1 (en) 2004-03-02 2005-08-23 St. Jude Medical Puerto Rico B.V. Three-needle closure device
US20050267520A1 (en) 2004-05-12 2005-12-01 Modesitt D B Access and closure device and method
US7344544B2 (en) 2005-03-28 2008-03-18 Cardica, Inc. Vascular closure system
US7883517B2 (en) 2005-08-08 2011-02-08 Abbott Laboratories Vascular suturing device
US7752853B2 (en) 2005-10-21 2010-07-13 Emerson Retail Services, Inc. Monitoring refrigerant in a refrigeration system
EP2182855A1 (en) 2007-08-08 2010-05-12 Spirx Closure, LLC Methods and devices for delivering sutures in tissue
US8333787B2 (en) 2007-12-31 2012-12-18 St. Jude Medical Puerto Rico Llc Vascular closure device having a flowable sealing material
US20090223426A1 (en) * 2008-03-04 2009-09-10 Harry Shonteff Micro sewing device
US20090306685A1 (en) 2008-06-10 2009-12-10 Ension, Inc. Noninvasive trans-catheter method and apparatus for remote suture placement such as for septal defect repair, left atrial appendage closure, pacemaker electrode placement, mitral valve repair, and other inner-cardiac and inner-arterial applications
JP2012500049A (en) 2008-08-13 2012-01-05 シルク・ロード・メディカル・インコーポレイテッド Suture delivery device
AU2009288440B2 (en) 2008-08-26 2015-04-23 St Jude Medical, Inc. Device and sealing component for sealing punctures
US8029476B2 (en) 2008-11-19 2011-10-04 Interrad Medical, Inc. Anchoring a medical instrument
US9414820B2 (en) 2009-01-09 2016-08-16 Abbott Vascular Inc. Closure devices, systems, and methods
US8252022B2 (en) 2009-07-13 2012-08-28 Vascular Solutions, Inc. Metal vascular aperture closure device
AU2011203802B2 (en) 2010-01-06 2015-02-19 St. Jude Medical, Inc. Method and system for sealing percutaneous punctures
EP2568886A1 (en) 2010-05-12 2013-03-20 St. Jude Medical, Inc. Bioadhesive applicator and methods of sealing tissue punctures using same
US9241708B2 (en) 2011-06-07 2016-01-26 St. Jude Medical Puerto Rico, Llc Large bore closure device and methods
WO2013112340A1 (en) 2012-01-24 2013-08-01 St. Jude Medical Puerto Rico Llc Bioresorbable tip with low force release
US9370345B2 (en) 2012-01-24 2016-06-21 St. Jude Medical Puerto Rico Llc Bioadhesive delivery catheter manifold with mixing fixture and methods
EP2811912B1 (en) 2012-01-24 2017-06-21 St. Jude Medical Puerto Rico LLC Balloon location device manifold for vascular closure device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5810851A (en) * 1996-03-05 1998-09-22 Yoon; Inbae Suture spring device
US20080215088A1 (en) 1998-11-06 2008-09-04 Neomend, Inc. Systems, Methods, and compositions for achieving closure of suture sites
US20080221616A1 (en) * 2000-01-05 2008-09-11 Integrated Vascular Systems, Inc. Integrated vascular device with puncture site closure component and sealant and methods of use
US20090054926A1 (en) * 2007-08-21 2009-02-26 St. Jude Medical Puerto Rico B.V. Extra-vascular sealing device and method
US20100185216A1 (en) * 2008-08-13 2010-07-22 Garrison Michi E Suture delivery device

Also Published As

Publication number Publication date
EP2967565A4 (en) 2016-11-30
US9055933B2 (en) 2015-06-16
EP2967565B1 (en) 2020-08-05
US20140276974A1 (en) 2014-09-18
EP2967565A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
EP1229841B1 (en) System for wound closure
US10307143B2 (en) Bioadhesive delivery catheter manifold with mixing fixture and methods
US11020104B2 (en) Vascular hole closure delivery device
US9078631B2 (en) Dual hypotube suture cutting device and methods
EP2967565B1 (en) Large bore closure secondary hemostasis bioadhesive delivery systems and methods
US9610076B2 (en) Wound closure device
US20170135692A1 (en) Systems and methods for helically advancing suture in tissue
US10285677B2 (en) Large bore anchor device
US9107646B2 (en) Active securement detachable sealing tip for extra-vascular closure device and methods
US20080287986A1 (en) Closure device
US20160120526A1 (en) Vascular closure apparatus and related method
US10016200B2 (en) Balloon bailout and bioadhesive delivery device for suture based closure and methods
US9655603B2 (en) Automatic sealant delivery catheter retraction for vascular closure device and methods
US20160220235A1 (en) Vascular closure apparatus and related method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14772819

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2014772819

Country of ref document: EP